| Date | Form | Description | Docs | XBRL | Pages |
| 10/21/05 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/07/05 | DEF 14A | Definitive proxy statements |
|
17 | |
| 09/29/05 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/09/05 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
25 | |
| 06/09/05 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
22 | |
| 05/02/05 | UPLOAD | SEC-generated letter |
|
1 | |
| 04/22/05 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
13 | |
| 04/15/05 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 04/01/05 | UPLOAD | SEC-generated letter |
|
3 | |
| 03/11/05 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...